Legal & General Group Plc - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 66 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q2 2024$17,748
+255.0%
3,825
+110.7%
0.00%
Q1 2022$5,000
-50.0%
1,8150.0%0.00%
Q4 2021$10,000
-81.5%
1,815
-71.9%
0.00%
Q3 2021$54,000
+100.0%
6,468
+194.1%
0.00%
Q2 2021$27,000
-62.5%
2,199
-26.3%
0.00%
Q1 2021$72,000
-11.1%
2,985
+17.6%
0.00%
Q4 2020$81,000
+5.2%
2,5390.0%0.00%
Q3 2020$77,000
-23.0%
2,539
+7.0%
0.00%
Q2 2020$100,000
+122.2%
2,374
+27.0%
0.00%
Q1 2020$45,0001,8700.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q1 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$104,289,0004.42%
Boxer Capital, LLC 2,014,858$60,909,0002.10%
RA Capital Management 2,589,904$78,293,0001.43%
Artal Group S.A. 1,521,517$45,995,0001.12%
Ikarian Capital, LLC 358,941$10,851,0000.78%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$24,260,0000.59%
Bellevue Group AG 1,403,000$42,413,0000.59%
Logos Global Management LP 123,465$3,732,0000.48%
Casdin Capital, LLC 289,395$8,748,0000.39%
HighVista Strategies LLC 16,391$496,0000.36%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders